Evolution of Growth following Anti-Tumor Necrosis Factor-α Therapy in Paediatric Crohn’s Disease: Data from the Swiss IBD Cohort Study
Our findings indicate that anti-TNF biologics are associated with significant short-term height and long-term weight gains in pediatric patients with Crohn's disease, similar to those observed with immunomodulators.
Authors
- Andreas Nydegger (ORCID: https://orcid.org/0000-0003-0063-3580)
- Alain Schoepfer (ORCID: https://orcid.org/0000-0001-6341-9536)
- Franziska Righini‐Grunder (ORCID: https://orcid.org/0000-0001-5762-8681)
- Christiane Sokollik (ORCID: https://orcid.org/0000-0002-5992-8247)
- Michela G Schaeppi Tempia
- Christina Kunz (ORCID: https://orcid.org/0009-0001-9483-2355)
- Henrik Köhler
- Mathilde Crédeville
- Vasikili Spyropoulou
Institutions
- University Hospital of Bern (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- University Hospital of Geneva (CH)
- University of Teacher Education Lucerne (CH)
- Hôpital Orthopédique de la Suisse Romande (CH)
- Hirslanden Clinique des Grangettes (CH)
- University Children's Hospital Zurich (CH)
- SGS (Switzerland) (CH)
- Kantonsspital Aarau (CH)
- Geneva College (US)
- University of Lausanne (CH)
Publication Details
- Journal
- Inflammatory Intestinal Diseases
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1159/000548730
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00